D. Hobuß, A. Baro, K. V. Axenov, S. Laschat, W. Frey
FULL PAPER
(1R,2R,4S,6S,8R)-N,N-Diethyl(4-boronato-2,9,9-trimethyl-3,5-dioxa-
4-phosphatricyclo[6.1.1.02,6]dec-4-yl)amine (6b) and (1R,2R,
4R,6S,8R)-N,N-Diethyl(4-boronato-2,9,9-trimethyl-3,5-dioxa-4-
phosphatricyclo[6.1.1.02,6]dec-4-yl)amine (7b): According to the ge-
neral procedure, treatment of 5b (522 mg, 3.00 mmol) with cis-pin-
andiol 2 (510 mg, 3.00 mmol) gave after flash chromatography sep-
aration [eluent: EtOAc/PE, 1:10, silica gel; Rf (6b) = 0.29, Rf (7b)
= 0.42] complexes 6b (167 mg, 20%) and 7b (205 mg, 24%).
parameters, 28 restraints (disorder of one ethyl function of the di-
ethylamino moiety); R1 = 0.0643, wR2 = 0.1641 {[IՆ2σ(I)]}; max.
(min.) residual electron density 0.270 (–0.225) eÅ–3; Flack param-
eter 0.0(2), data collection with a Nicolet P3F diffractometer.
(1R,2R,4S,6S,8R)-N,N-Diisopropyl-(4-boronato-2,9,9-trimethyl-3,5-
dioxa-4-phosphatricyclo[6.1.1.02,6]dec-4-yl)amine (6c) and (1R,2R,
4R,6S,8R)-N,N-Diisopropyl-(4-boronato-2,9,9-trimethyl-3,5-dioxa-
4-phosphatricyclo[6.1.1.02,6]dec-4-yl)amine (7c): According to the
general procedure, treatment of 5c (1.61 g, 8.00 mmol) with cis-
pinandiol 2 (1.36 g, 8.00 mmol), Et3N (2.24 mL, 16 mmol), and
BH3·THF complex (1 m solution in THF, 8.00 mL, 8.00 mmol) in
Complex 6b: M.p. 85 °C. C14H29BNO2P (285.17): calcd. C 58.97,
H 10.25, N 4.91; found C 59.29, H 10.15, N 4.57. 1H NMR
1
(250 MHz, CDCl3, 298 K): δ = 0.69 (1:1:1:1 br. q, JB,H = 90 Hz,
3 H, BH3), 0.87 (s, 3 H, 12-H), 1.12 (t, 3JH,H = 7.0 Hz, 6 H, CH3Et), THF (20 mL) gave after flash chromatography separation [eluent:
1.30, 1.56 (each s, each 3 H, 11 and 11Ј-H), 1.94 (m, 1 H, 8-H),
EtOAc/PE, 1:10, silica gel; Rf (6c) = 0.31, Rf (7c) = 0.47] complexes
6c (851 mg, 34%) and 7c (778 mg, 31%).
2
1.98 (d, JH,H = 10.8 Hz, 10-Hax), 2.13 (m, 1 H, 7-Hax), 2.17 (t,
2
3
3JH,H = 5.5 Hz, 1 H, 1-H), 2.24 (dtd, JH,H = 10.8 Hz, JH,H
=
=
Complex 6c: M.p. 130–131 °C. C16H33BNO2P (313.23): calcd. C
5.5 Hz, JH,H = 2.2 Hz, 1 H, 10-Heq), 2.41 (AB type ddt, JH,H
3
2
1
61.35, H 10.62, N 4.47; found C 61.47, H 10.51, N 4.47. H NMR
14.9 Hz, JH,H-trans = 8.9 Hz, JH,H = 2.4 Hz, 1 H, 7-Heq), 3.15 (m,
3
3
1
(250 MHz, CDCl3, 298 K): δ = 0.83 (1:1:1:1 br. q, JB,H = 87 Hz,
3
3
3
4 H, CH2Et), 4.58 (ddd, JP,H = 9.7 Hz, JH,H-trans = 8.9 Hz, JH,H-
3
3 H, BH3), 0.87 (s, 3 H, 12-H), 1.29, 1.32 [each d, JH,H = 7.0 Hz,
= 2.8 Hz, 1 H, 6-H) ppm. 13C{1H} NMR (63 MHz, CDCl3,
cis
each 6 H, CH3iPr(A) and CH3iPr(B)], 1.30, 1.57 (each s, each 3 H, 11
298 K): δ = 14.1 (d, JP,C = 2.0 Hz, CH3Et), 24.4 (C-12), 26.3 (C-
3
2
and 11Ј-H), 1.93 (m, 1 H, 8-H), 2.02 (d, JH,H = 10.5 Hz, 10-Hax),
10), 27.1, 28.4 (C-11 and C-11Ј), 35.0 (d, 3JP,C = 3.7 Hz, C-7), 38.7
3
2.16 (m, 1 H, 7-Hax), 2.17 (t, JH,H = 5.3 Hz, 1 H, 1-H), 2.22 (m,
(d, JP,C = 5.6 Hz, CH2Et), 38.8 (C-9), 39.4 (C-8), 52.2 (d, JP,C
=
2
3
2
3
1 H, 10-Heq), 2.42 (AB type ddt, JH,H = 14.8 Hz, JH,H-trans
=
=
2
2
5.6 Hz, C-1), 79.2 (d, JP,C = 4.5 Hz, C-6), 89.0 (d, JP,C = 7.2 Hz,
8.8 Hz, JH,H = 2.4 Hz, 1 H, 7-Heq), 3.71 (d of septet, JP,H
3
3
C-2) ppm. 31P{1H} NMR (162 MHz, C6D6, 298 K) δ = 144.8 ppm.
15.1 Hz, JH,H = 7.0 Hz, 2 H, CHiPr), 4.60 (ddd, JP,H = 9.3 Hz,
3
3
IR (film): ν = 2976, 2931, 2874, 2387, 2255, 2145, 1741, 1466, 1449,
˜
3JH,H-trans = 8.8 Hz, JH,H-cis = 2.7 Hz, 1 H, 6-H) ppm. 13C{1H}
3
1382, 1264, 1210, 1173, 1134, 1077, 1027, 1007, 990, 953, 338, 898,
870, 806, 789, 693, 643 cm–1. MS (EI): m/z (%) = 285 (3) [M+], 272
(8), 271 (69) [M+ – BH3], 256 (7), 242 (1), 228 (2), 199 (3), 165 (3),
164 (40), 148 (2), 138 (9), 135 (23), 120 (23), 94 (13), 93 (100), 79
(8), 72 (24), 58 (8), 44 (3), 43 (12), 28 (19). [α]2D0 = Ϯ 0 (c = 1,
CHCl3).
3
NMR (63 MHz, CDCl3, 298 K): δ = 22.7, 23.5 [two d, JP,C = 2.0/
2.3 Hz, CH3iPr(A) and CH3iPr(B)], 24.4 (C-12), 26.1 (C-10), 27.1, 28.6
(C-11 and C-11Ј), 35.0 (d, 3JP,C = 4.0 Hz, C-7), 38.8 (C-9), 39.5 (C-
8), 46.1 (d, JP,C = 6.2 Hz, CHiPr), 52.5 (d, JP,C = 5.9 Hz, C-1),
2
3
2
2
79.5 (d, JP,C = 5.3 Hz, C-6), 89.6 (d, JP,C = 7.7 Hz, C-2) ppm.
31P{1H} NMR (121 MHz, C6D6, 298 K): δ = 145.1 ppm. IR (film):
Complex 7b: M.p. 51 °C. C14H29BNO2P (285.17): calcd. C 58.97,
ν = 2976, 2933 (s), 2875, 2397 (s), 2269, 2160, 1634, 1474, 1449,
˜
H 10.25, N 4.91; found C 59.08, H 10.14, N 4.85. 1H NMR
1411, 1387, 1369, 1313, 1282, 1264, 1243, 1205, 1182, 1157, 1122,
1
(250 MHz, CDCl3, 298 K): δ = 0.66 (1:1:1:1 br. q, JB,H = 88 Hz,
1077, 1057, 1010, 985 (s), 838, 918, 894, 871, 852 cm–1. MS (EI):
3 H, BH3), 0.88 (s, 3 H, 12-H), 1.13 (t, 3JH,H = 7.1 Hz, 6 H, CH3Et), m/z (%) = 313 (3) [M+], 300 (13), 299 (70) [M+ – BH3], 284 (16),
2
1.32, 1.66 (each s, each 3 H, 11 and 11Ј-H), 1.58 (d, JH,H
=
257 (3), 256 (15), 217 (1), 200 (1), 199 (4), 192 (10), 176 (1), 166
10.3 Hz, 10-Hax), 1.98 (m, 1 H, 8-H), 2.02 (dm, JH,H = 14.0 Hz, 1 (5), 150 (10), 136 (23), 135 (35), 94 (6), 93 (100), 79 (6), 55 (7), 43
2
3
2
H, 7-Hax), 2.18 (t, JH,H = 5.6 Hz, 1 H, 1-H), 2.25 (dtd, JH,H
=
(23), 27 (5). [α]2D0 = +6.5 (c = 1, CH2Cl2). Ligand 6c was deprotected
10.3 Hz, JH,H = 5.6 Hz, JH,H = 1.8 Hz, 1 H, 10-Heq), 2.43 (dm, by heating at 65 °C for 12 h with an excess amount of Et2NH.
2JH,H = 14.0 Hz, 1 H, 7-Heq), 3.25 (m, 4 H, CH2Et), 4.47 (ddd, 3JP,H 31P{1H} NMR spectrum of free ligand 8c (121 MHz, C6D6, 298 K):
= 9.0 Hz, JH,H-trans = 6.7 Hz, JH,H-cis = 2.4 Hz, 1 H, 6-H) ppm. δ = 151.8 ppm. The free ligand was treated with BH3·THF complex
3
3
3
3
3
13C{1H} NMR (63 MHz, CDCl3, 298 K): δ = 14.4 (d, JP,C
=
at 0 °C for 2 h to give back complex 6c [31P(1H) NMR (121 MHz,
1.6 Hz, CH3Et), 24.3 (C-12), 25.5 (C-10), 27.1, 28.5 (C-11 and C- C6D6, 298 K): δ = 145.1 ppm].
11Ј), 34.4 (d, JP,C = 3.5 Hz, C-7), 39.0 (d, JP,C = 6.3 Hz, CH2Et),
3
2
Complex 7c: M.p. 82 °C. C16H33BNO2P (313.23): calcd. C 61.35,
39.1 (C-9), 39.8 (C-8), 52.0 (d, 3JP,C = 4.4 Hz, C-1), 76.4 (C-6), 85.7
H 10.62, N 4.47; found C 61.10, H 10.56, N 4.19. 1H NMR
(C-2) ppm. 31P{1H} NMR (162 MHz, C6D6, 298 K):
δ =
1
(250 MHz, CDCl3, 298 K): δ = 0.77 (1:1:1:1 br. q, JB,H = 87 Hz,
142.8 ppm. IR (film): ν = 2980, 2936 (s), 2871, 2382 (s), 2351, 2247,
˜
3
3 H, BH3), 0.88 (s, 3 H, 12-H), 1.31, 1.32 [each d, JH,H = 7.0 Hz,
2117, 2009, 1722, 1453, 1382, 1292, 1248, 1208, 1173, 1130, 1078,
1029, 1008, 989, 960, 936, 915, 889, 870, 837, 800, 790, 733, 691,
631 cm–1. MS (EI): m/z (%) = 285 (1) [M+], 273 (1), 272 (12), 271
(72) [M+ – BH3], 256 (9), 242 (1), 228 (3), 199 (3), 165 (1), 164 (8),
148 (1), 138 (15), 135 (26), 120 (22), 94 (10), 93 (100), 79 (7), 72
(25), 58 (9), 44 (3), 43 (12), 29 (3), 28 (14). [α]2D0 = –49.4 (c = 1,
CHCl3).
each 6 H, CH3iPr(A) and CH3iPr(B)], 1.31, 1.70 (each s, each 3 H, 11
2
and 11Ј-H), 1.59 (d, JH,H = 10.2 Hz, 10-Hax), 1.96 (m, 1 H, 8-H),
2.01 (dm, 2JH,H = 14.6 Hz, 1 H, 7-Hax), 2.18 (t, 3JH,H = 5.4 Hz, 1 H,
1-H), 2.21 (dtd, 2JH,H = 10.2 Hz, 3JH,H = 5.4 Hz, 3JH,H = 2.2 Hz, 1
2
3
H, 10-Heq), 2.43 (AB type ddm, JH,H = 14.6 Hz, JH,H-trans
=
=
8.8 Hz, 1 H, 7-Heq), 3.97 (d of septet, JP,H = 15.5 Hz, JH,H
3
3
7.0 Hz, 2 H, CHiPr), 4.50 (ddd, JH,H-trans = 8.8 Hz, JP,H = 6.0,
3
3
X-ray Crystal Structure Analysis of Complex 6b: Formula
C14H29BNO2P; colorless crystal 0.9ϫ0.6ϫ0.5 mm; Mr = 285.16;
3JH,H-cis = 2.1 Hz, 1 H, 6-H) ppm. 13C{1H} NMR (63 MHz,
3
iPr(A)
CDCl3, 298 K): δ = 23.1, 23.2 [two d, JP,C = 2.1/2.6 Hz, CH3
a
=
7.548(3) Å,
b
=
10.880(4) Å,
c
=
21.343 (7) Å;
V
=
and CH3iPr(B)], 24.4 (C-12), 25.3 (C-10), 27.1, 28.8 (C-11 and C-
1752.8(11) Å3; ρcalcd. = 1.081 gcm–3; μ = 0.1550 mm–1; Z = 4; or-
thorhombic, space group P212121 (no. 19); λ = 0.71073 Å; T =
293(2) K; Wyckoff scan, 3140 reflections collected (–1ՅhՅ9,
–1ՅkՅ14, –1ՅlՅ28), [(sinθ)/λ] = 0.66 Å–1; 2966 independent
(Rint = 0.0605) and 1886 observed reflections [IՆ2σ(I)]; 192 refined
11Ј), 34.2 (d, JP,C = 3.6 Hz, C-7), 39.2 (C-9), 39.8 (C-8), 46.2 (d,
3
2JP,C = 6.1 Hz, CHiPr), 52.3 (d, JP,C = 3.9 Hz, C-1), 76.1 (C-6),
3
85.7 (C-2) ppm. 31P{1H} NMR (162 MHz, C6D6, 298 K): δ =
143.2 ppm. IR (neat): ν = 3580, 2985, 2915, 2874, 2397 (s), 2354,
˜
2276, 2177, 2148, 2018, 1967, 1648, 1472, 1451, 1409, 1387, 1370,
390
www.eurjic.org
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2011, 384–392